Press Statement | 11 August 2009 | Download PDF
As the dispute continues over the seizures of legitimate generic medicines in transit (see recent articles in Wall Street Journal, Financial Times, PharmaTimes, and SCRIP World Pharmaceutical News), Health Action International continues to call for the European Union to revisit EU regulation 1383/2003, which has perpetuated the dangerous confusion between counterfeit pharmaceutical products and legitimate generic medicines.